Clinical Trial Update: Human Amniotic Epithelial Cells for Asherman's Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating human amniotic epithelial cells for Asherman's syndrome; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asherman Syndrome

Drugs mentioned

• Human Amniotic Epithelial Cells (human amniotic epithelial cells)

Snippet

Sponsor: The Second Affiliated Hospital of Chongqing Medical University | Conditions: Asherman's Syndrome | Phase 1 | Status: UNKNOWN